SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-024748
Filing Date
2019-02-01
Accepted
2019-02-01 08:00:35
Documents
2
Period of Report
2019-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d702573d8k.htm 8-K 17122
2 EX-10.1 d702573dex101.htm EX-10.1 95832
  Complete submission text file 0001193125-19-024748.txt   114057
Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 19557749
SIC: 2834 Pharmaceutical Preparations